Abstract
In Part I of this review, melatonin's effects in general medicine were discussed, along with a discussion of safety. Part II of this review focuses on the uses of melatonin in oncology. This includes a discussion of the uses of melatonin in breast cancer patients, including those receiving surgery, radiation, chemotherapy, and endocrine therapy. The uses of melatonin alongside additional conventional therapies for people with other types of cancer are also discussed. Studies utilizing melatonin for people with metastatic disease are also reviewed. Lastly, a brief discussion of melatonin alongside immunotherapy is included.
Get full access to this article
View all access options for this article.
